e-learning
resources
ERJ
2001
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tissue inhibitor of metalloproteinases-;2 gene polymorphisms in chronic obstructive pulmonary disease
Hirano K., Sakamoto T., Uchida Y., Morishima Y., Masuyama K., Ishii Y., Nomura A., Ohtsuka M., Sekizawa K.
Source:
Eur Respir J 2001; 18: 748-752
Journal Issue:
November
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hirano K., Sakamoto T., Uchida Y., Morishima Y., Masuyama K., Ishii Y., Nomura A., Ohtsuka M., Sekizawa K.. Tissue inhibitor of metalloproteinases-;2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 2001; 18: 748-752
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 521s
Year: 2001
Angiotensin-converting-enzyme gene polymorphism and susceptibility to chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 195s
Year: 2002
Matrix metalloproteinases and lung disease severity in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001
Genetic polymorphisms in MMP9 and TIMP2 genes and risk of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
Polymorphism of the cyclo-oxygenase-2 gene protects against the development of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 439s
Year: 2005
Genetic susceptibility to chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=84
Year: 2006
To correlate of the NOS1 C/T polymorphism with the activity of proteases and antiproteases in the serum and sputum in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2006; 28: Suppl. 50, 585s
Year: 2006
Effect of phosphodiesterase 5 inhibitor in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Polymorphism of NRAMP1 gene in chronic obstructive pulmonary disease patients
Source: Eur Respir J 2004; 24: Suppl. 48, 315s
Year: 2004
Polymorphism of collagen I gene and glutation-S-transferases T1 and M1 in chronic obstructive pulmonary disease associated with cardiovascular disease
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients
Source: Eur Respir J 2008; 32: 372-378
Year: 2008
Desmosin as a marker for tissue injury in COPD
Source: Annual Congress 2007 - α
1
-Antitrypsin deficiency: molecular and clinical news
Year: 2007
Elastin expression in very severe human COPD
Source: Eur Respir J 2009; 33: 324-331
Year: 2009
Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 20s
Year: 2003
Expression of matrix metalloproteinases and TIMP inhibitors in circulation/lung in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD
Source: Eur Respir J 2013; 41: 1042-1050
Year: 2013
The role of matrix metalloproteinase-9 in the formation of chronic obstructive pulmonary disease associated with coronary heart disease
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept